Case report of primary serous adenocarcinoma of fallopian tube - a diagnostic dilemma
Gayam S.1, Babu C.2, V.V.S. L.3, Maddali S.4
1Dr. Susheela Gayam, Department of Obstetrics and Gynaecology, Vijay Marie Hospital, Hyderabad, India, 2Dr. Chinna Babu, Dept of Surgical Oncology, Apollo Hospital, Hyderabad, India, 3Dr. Lakshmi V.V.S, Department of Obstetrics and Gynaecology, Vijay Marie Hospital, Hyderabad, India, 4Dr. Srinivas Maddali, Histopathology & Cytology Laboratory, Hyderabad, India
Corresponding Authors: Dr.
Susheela Gayam, Department of Obstetrics and Gynaecology, Vijay Marie
Hospital, Hyderabad, India. E-mail: sushgayam@yahoo.com
Abstract
Historically,
primary fallopian tube carcinoma constitutes 0.3% of all cancers of the
female genital tract. But literature suggests that the primary
fallopian tube carcinoma may be more common. The true incidence of
fallopian tube cancer may be underestimated because of the convention
of assigning many of these as ovarian cancer when the site of origin is
unclear. The preoperative diagnosis is difficult due to the lack of
specific symptoms. Fallopian tube carcinoma clinically behaves like epithelial ovarian cancer and histologically similar
to it; thus, the evaluation and treatment are essentially the same. We
report here a typical case of primary fallopian tube cancer in a 48
year old female diagnosed as ovarian tumour, preoperatively by
radiological imaging but was recognized as fallopian tube carcinoma
intraoperatively and was confirmed by histopathology.
Keywords: Primary
fallopian tube neoplasm, Intra-operative Evaluation, Surgical
Procedure, Histopathological Diagnosis, Serous Adenocarcinoma, Staging, Chemotherapy
Author Corrected: 16th December 2018 Accepted for Publication: 20th December 2018
Introduction
Primary
fallopian tube carcinoma (PFTC) is a very rare gynecologic malignant
tumor and accounts for approximately 0.14-1.8% of female genital
malignancies [1, 2].
The
etiology of this tumour is unknown; it is suggested to be associated
with chronic tubal inflammation, infertility, tuberculous salpingitis
and tubal endometriosis [3]. Similar to ovarian malignancy, a BRCA germ
line mutation and TP53 mutation are associated with fallopian tube
malignancy [4,5]. Many patients, with fallopian tube carcinoma are
asymptomatic. The most common clinical features associated with it are
abdominal pain, vaginal bleeding, hydrohematorrhea, and palpation of a
pelvic mass/an adnexal mass [6]. Due to its rarity, preoperative
diagnosis of primary fallopian tube carcinoma is hardly ever made. It
is usually misdiagnosed as ovarian carcinoma, tuboovarian abscess or
ectopic pregnancy. Sonographic features of the tumor are non-specific
and include the presence of a fluid-filled, adnexal structure with a
significant solid component, a sausage-shaped mass, a cystic mass with
papillary projections within, a cystic mass with cog wheel appearance
and an ovoid-shaped structure containing an incomplete separation and a
highly vascular solid nodule. More than 80% of patients have elevated
pretreatment serum CA-125 levels, which is useful in follow-up after
the definite treatment [3]. The treatment approach is similar to that
of ovarian carcinoma, and includes Staging laparotomy, total abdominal
hysterectomy and bilateral salpingo-oophorectomy. Surgery is followed
by chemotherapy [3].
Case Report
A
48-year old female, P2L2 who had regular periods, presented with watery
vaginal discharge intermittently mixed with blood for 2 months. Past
medical or surgical history was nil significant and there was no
noteworthy family or personal history. General physical and systemic
examination was normal. On examination, abdomen was soft and nontender.
There was no palpable mass or free fluid noted. Per speculum
examination revealed healthy cervix and moist vagina. There was no
bleeding through the cervical OS. Bimanual examination revealed normal
sized anteverted uterus. A firm and non tender mass of 6x6cm was felt
separately from the uterus in the left fornix. The other fornices were
free and non tender.
Pelvic
Sonography showed uterus with normal echotexture measuring108x63x52mm,
endometrial thickness of 7 mm. Right ovary measured 28x21mm and left
ovary 28x20mm both with normal echo texture. A well-define disoechoec
lesion of size 59x54x69 mm noted in the left adnexal
region suggestive of left adnexal complex cyst/endometrioma. Mild free
fluid in pelvis was noted. CECT abdomen showed uterus measured
88x52x48cm; endometrial thickness 7mm, homogenously enhancing soft
tissue mass lesion in the left adnexa with poor delineation of left
ovary measures 50x51x55mm (AP x TR x CC) likely suggestive of primary
ovarian neoplasm. Noted mild ascites, and few enlarged lymph nodes in
the paraaortic and aortocaval region with largest measuring 15x6mm.
Liver was normal in contour and attenuation; no focal or diffuse
lesions. The tumour markers, CA 125 result was 2586U/ml; CA-19-9 and
CEA were within normal limits. Routine surgical profile, liver and
renal function tests were within normal limits. Chest X-ray and 2DEcho
were normal. Pap smear was normal. A diagnostic Curettage was done
which showed non secretary endometrium and no atypia. The clinical and
radiological findings suggested a left adnexal tumour with grossly
elevated CA-125 level.
Staging laparotomy and frozen section were planned in view of a complex ovarian mass. On opening the abdomen, a very obvious solid polypoid growth of 5x5x7cm was found arising from the fimbrial end of the left fallopian tube (Figures 1 & 2).
Figure 1: Intraoperative - Solid tumour arising from fimbrial end of the left fallopian tube and normal appearing ovaries (Black Arrows)
Figure 2: Surgical Specimen of Hysterectomy showing solid growth at fimbrial end of the left fallopian tube and normal Right FT.
About
100ml of haemorrhagic peritoneal fluid was present in the pelvis and it
was aspirated and sent for cytology. The right fallopian tube and both
the ovaries appeared normal. Uterovesical fold of peritoneum and
peritoneum of pouch of Douglas appeared thickened and congested. Both
left and right paracolic gutters, liver surface, the sub-diaphragmatic
surfaces, omentum and the rest of viscera appeared normal and no
deposits noted. Two paraortic lymph nodes were enlarged to 1.5 x 1cm
size. The patient underwent staging laparotomy, total abdominal
hysterectomy, bilateral salpingo-oophorectomy, total omentectomy and
pelvic and paraaotic lymphadenectomy. Anteriorly, uterovesical fold and
posteriorly, POD peritonectomy was also done as there were doubtful
small deposits. A thorough peritoneal wash was given.
The uterus with adnexae, omentum, the pelvic and paraaortic lymph nodes, and the peritoneal biopsies were sent for histopathological examination. Ascitic fluid cytology was negative for malignant cells. The histpathological examination was indicative of poorly differentiated serous adenocarcinoma of left fallopian tube, solid pattern, (figures 3 & 4) with tumour present on serosal surface. HPE was suggestive of Histologic grade III and Nuclear grade II. The uterus, the right fallopian tube and both the ovaries were free of tumour. The endometrium wasnon secretary with no atypia. No lymphovascualr invasion (LVI), or blood vessel invasion (BVI) or tumour on the serosal surface of uterus was detected. Samples from sub diaphragmatic and paracolic sites were negative for malignancy. All the pelvic and paraaortic lymph nodes were also found negative for malignancy. A diagnosis of 'Primary Serous Adenocarcinoma' of the left fallopian tube with HP Grade III, Nuclear grade II and Pathological Stage IC was made.
Figure-3: Low power microscopic featuresshowing poorly differentiated serous adenocarcinoma of fallopian tube
Figure-4: High power microscopic features showing poorly differentiated serous adenocarcinoma of fallopian tube
The
patient was discharged seven days after the surgery and was referred
for adjuvant chemotherapy. The patient received combination
chemotherapy with Paclitaxel and Carboplatin. She tolerated all the
cycle. Patent is under regular follow up. In this case, the
pre-operative diagnosis made by the clinical and radiological
evaluation was incorrect. Fallopian tube carcinomas are difficult to
diagnose preoperatively due to infrequency and clinically silent course
of this neoplasm.
Discussion
Primary
fallopian tube cancer resembles epithelial ovarian cancers clinically
and histologically [7]. Primary fallopian tube cancer is the rarest
malignancy of the female genital tract and commonly occurs between
fourth and sixth decades of life. It was first described by Renand in
1897 [8]. Rokitansky recorded the first microscopic description in 1861 and Orthman presented a first case report in 1888 [9]. Due
to its rarity, preoperative diagnosis of primary fallopian tube
carcinoma is seldom made. Vaginal discharge or bleeding is the most
common symptom reported by patients with tubal carcinoma and is
documented in more than 50% of patients. Though this patient presented
clinically with watery discharge and a pelvic mass but radiologically
it was diagnosed as ovarian tumour. It is also cited in the literature
that due to its infrequency, it is typically misdiagnosed as ovarian
carcinoma. 3 The
preoperative diagnosis of primary fallopian tube cancer is extremely
rare [10]. The rate of preoperative diagnosis was in the range of
0%-10%, and up to 50% are missed intraoperatively [11, 12]. It
was noted in this patient a very high levels of CA 125 preoperatively.
80% of patients with PFTC do have elevated pretreatment serum levels of
CA 125 [13]. Surgery
is the treatment of choice for PFTC and is similar to that for ovarian
carcinoma-cytoreductive surgery with the removal of the tumour as much
as possible. The procedure of choice is total abdominal hysterectomy,
bilateral salpingo-oophorectomy, omentectomy, selective pelvic and
para-aortic lymphadenectomy for any stage of fallopian tube carcinoma
[14, 15]. This patient also underwent staging laparotomy, total
abdominal hysterectomy and total omentectomy and pelvic and paraaortic
lymphadenectomy and the diagnosis of PFTC was confirmed by
histopathology and Stage IC wasmade. Postoperative adjuvant
chemotherapy with platinum based combination is the most commonly used
therapy for these patients, similar to epithelial ovarian cancer
patients [16]. The reported 5-year survival rate for patients with stage I disease is about 65%.
Conclusion
Primary fallopian tube cancer is
a rare tumour which accounts for < 1% of all the female genital
tract cancers. Primary fallopian Tubal cancers are seen normally in
postmenopausal women, in the fifth and sixth decades. Latzko’
classic triad of symptoms and signs associated with fallopian tube
cancer is a prominent watery vaginal discharge (ie hydrops
tubaeprofluens), Pelvic pain, and a pelvic mass. This triad is noted in
fewer than 15% of patients. The symptoms may be rather vague and non
specific. Most commonly involved site is the ampullary part of the
fallopian tube. The most common Histologic variant is papillary serous
carcinoma. Because the lumen and fimbria of the fallopian tube have
access to the peritoneal cavity, fallopian tube carcinomas frequently
involve the omentum and peritoneal cavity at the time of presentation.
In histologic features and behavior, fallopian tube carcinoma is
similar to ovarian cancer; thus, the evaluation and treatment are
essentially the same. Surgery is the treatment of choice. Exploratory
laparotomy is necessary to remove the primary tumor, to stage the
disease, and to resect metastases. In view of the early lymphatic
spread, the role of the routine lymph node removal is mandatory in primary fallopian tube cancer. Cytoreductive
surgery followed by adequate cycles of platinum based combination
chemotherapy is an important strategy to improve patients’
prognosis.
Competing Interests: The authors have declared that no competing interests exist.
Consent of Patient: Written
informed consent was obtained from the patient for publication of this
case report and the accompanying images. A copy of the written consent
is available for review by the Editor-in-Chief of this journal.
References
How to cite this article?
Gayam S, Babu C, V.V.S. L, Maddali S. Case report of primary serous adenocarcinoma of fallopian tube- a diagnostic dilemma.Obg Rev:J obstet Gynecol 2018;4(4):73-76.doi:10.17511/jobg.2018.i4.01.